These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8876672)

  • 1. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
    Fernandes ER; Ashendel CL
    Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
    Weyman CM; Taparowsky EJ; Wolfson M; Ashendel CL
    Cancer Res; 1988 Nov; 48(22):6535-41. PubMed ID: 3052806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon.
    Borner C; Guadagno SN; Hsieh LL; Hsiao WL; Weinstein IB
    Cell Growth Differ; 1990 Dec; 1(12):653-60. PubMed ID: 2288879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
    Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G
    Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation.
    Barr LF; Mabry M; Nelkin BD; Tyler G; May WS; Baylin SB
    Cancer Res; 1991 Oct; 51(20):5514-9. PubMed ID: 1655253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures.
    Harrington MA; Daub R; Song A; Stasek J; Garcia JG
    Cell Growth Differ; 1992 Apr; 3(4):241-8. PubMed ID: 1325182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C.
    Krauss RS; Housey GM; Johnson MD; Weinstein IB
    Oncogene; 1989 Aug; 4(8):991-8. PubMed ID: 2761987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments.
    Dunn JA; Faletto MB; Kasper SJ; Gurtoo HL
    Cancer Res; 1992 Feb; 52(4):990-6. PubMed ID: 1737362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system.
    Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N
    Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
    Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
    Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.